Mark Westerman, Ph.D.

Bio - Mark Westerman

Mark Westerman founded Intrinsic LifeSciences (ILS) in 2006 along with Drs. Tomas Ganz and Elizabeta Nemeth, and has served as President & CEO since. After postdoctoral research at Scripps Institution of Oceanography and as a National Research Council Fellow to NOAA, he built and directed an internationally recognized marine biotechnology program focused on advanced vaccine and diagnostics technologies.

Dr. Westerman and his corporate and academic colleagues discovered and characterized bass hepcidin soon after its discovery in humans by Tomas Ganz (UCLA, David Geffen School of Medicine). He was instrumental in development of a novel serum hepcidin ELISA and was awarded two patents related to the company’s products. Dr. Westerman has authored two patent applications in prosecution and over 25 peer reviewed scientific articles, and serves as an Editorial Board Member of Marine Biotechnology. He holds a Masters degree from the University of Texas at Austin and a Ph.D. from Texas A&M University.

Mark Westerman’s Selected Publications:



For the full list of publications, click here